Endo Hit With FDA Warning Over Vaginal Mesh Facility
Pharmaceutical company Endo International PLC has received a warning letter from the U.S. Food and Drug Administration concerning issues found after an inspection at its embattled vaginal mesh products subsidiary's Minnesota...To view the full article, register now.
Already a subscriber? Click here to view full article